Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.
Carrié D, Delarche N, Piot C, Berland J, Menneveau N, Bonello L, Py A, Teiger E, Leborgne L, Bayet G, Wittenberg O, Schiele F. Carrié D, et al. Among authors: berland j. EuroIntervention. 2014 Oct;10(6):700-8. doi: 10.4244/EIJV10I6A122. EuroIntervention. 2014. PMID: 24334825 Free article. Clinical Trial.
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V, Berland J, Barragan P, Waliszewski M, Bonello L, Delarche N, Furber A, Albert F, Carrié D, Eltchaninoff H, Pansieri M, Schneeberger M, Piot C, Marcollet P, Bedossa M. Auffret V, et al. Among authors: berland j. Int J Cardiol. 2016 Jan 15;203:690-6. doi: 10.1016/j.ijcard.2015.11.031. Epub 2015 Nov 6. Int J Cardiol. 2016. PMID: 26583844 Free article.
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy.
Kereiakes DJ, Meredith IT, Masotti M, Carrié D, Moreno R, Erglis A, Mehta SR, Elhadad S, Berland J, Stein B, Airaksinen J, Jobe RL, Reitman A, Janssens L, Christen T, Dawkins KD, Windecker S. Kereiakes DJ, et al. Among authors: berland j. EuroIntervention. 2017 Mar 20;12(16):1987-1994. doi: 10.4244/EIJ-D-16-00643. EuroIntervention. 2017. PMID: 27840326 Free article. Clinical Trial.
Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial.
Costa RA, Abizaid A, Abizaid AS, Garcia del Blanco B, Berland J, Petrov I, Brenot P, van Guens RJ, Royer T, Rubino P, Lesiak M, Fajadet J; BIPAX Investigators. Costa RA, et al. Among authors: berland j. EuroIntervention. 2012 Mar;7(11):1301-9. doi: 10.4244/EIJV7I11A205. EuroIntervention. 2012. PMID: 22433193 Free article. Clinical Trial.
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.
Lipiecki J, Brunel P, Morice MC, Roguelov C, Walsh SJ, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll HP, Urban P. Lipiecki J, et al. Among authors: berland j. EuroIntervention. 2018 Jul 20;14(4):e418-e425. doi: 10.4244/EIJ-D-18-00293. EuroIntervention. 2018. PMID: 29790477 Free article. Clinical Trial.
Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.
Carrié D, Berland J, Verheye S, Hauptmann KE, Vrolix M, Musto C, Berti S, Dibié A, Maupas E, Antoniucci D, Schofer J. Carrié D, et al. Among authors: berland j. Int J Cardiol. 2020 Feb 15;301:50-55. doi: 10.1016/j.ijcard.2019.10.058. Epub 2019 Nov 15. Int J Cardiol. 2020. PMID: 31759686 Clinical Trial.
Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.
Rioufol G, Dérimay F, Roubille F, Perret T, Motreff P, Angoulvant D, Cottin Y, Meunier L, Cetran L, Cayla G, Harbaoui B, Wiedemann JY, Van Belle É, Pouillot C, Noirclerc N, Morelle JF, Soto FX, Caussin C, Bertrand B, Lefèvre T, Dupouy P, Lesault PF, Albert F, Barthelemy O, Koning R, Leborgne L, Barnay P, Chapon P, Armero S, Lafont A, Piot C, Amaz C, Vaz B, Benyahya L, Varillon Y, Ovize M, Mewton N, Finet G; FUTURE Trial Investigators. Rioufol G, et al. J Am Coll Cardiol. 2021 Nov 9;78(19):1875-1885. doi: 10.1016/j.jacc.2021.08.061. J Am Coll Cardiol. 2021. PMID: 34736563 Free article. Clinical Trial.
STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial.
van Geuns RJ, Yetgin T, La Manna A, Tamburino C, Souteyrand G, Motreff P, Koch KT, Vrolix M, IJsselmuiden A, Amoroso G, Berland J, Montalescot G, Teiger E, Christiansen EH, Spaargaren R, Wijns W. van Geuns RJ, et al. Among authors: berland j. EuroIntervention. 2016 Feb;11(11):e1267-74. doi: 10.4244/EIJV11I11A248. EuroIntervention. 2016. PMID: 26865444 Free article. Clinical Trial.
163 results